3 income shares retirees should consider buying today

Transurban Group (ASX:TCL) is one of three ASX shares which I feel retirees should consider buying today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to building a successful retirement portfolio I believe investors should avoid speculative high-risk shares and focus solely on high-quality shares with strong core businesses that will still be around in 30 years.

Companies with strong competitive advantages and a track record of growing their dividends would definitely be part of my retirement portfolio. Fortunately for Australian investors there are a number of shares on the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) which I believe fit these criteria.

Here are three shares from different sectors which I think retirees should consider buying today:

Ramsay Health Care Limited (ASX: RHC)

I believe this private hospital operator is the best healthcare share on the ASX and would make a great addition to a retirement portfolio today.

Management stated in a recent presentation that it sees demand for hospital care services continuing to grow thanks to ageing populations, increased chronic disease burden, and improvements in treatment and diagnostic methods. As it has 221 hospitals across six countries, 25,000 beds, and 50 years of experience in the industry, I feel Ramsay Health Care is positioned perfectly for long-term growth.

Although its shares only provide a fully franked 1.5% dividend at present, the company has grown its dividend by over 17% per annum for the last 10 years. Due to its strong growth potential I expect this to continue for some time to come, making it a great combination of growth and income in my opinion.

Transurban Group (ASX: TCL)

Whilst its shares do not come cheap, Transurban Group is the blue-chip king in my opinion. The toll road giant has the rights to operate a number of vital toll roads in Australia for at least the next two decades. This puts the company in an incredibly commanding position, especially as Australia's population increases and its roads get even more congested.

As a result I expect earnings to grow at a solid rate for the foreseeable future which should help support its growing dividend. After seven successive years of dividend increases Transurban Group shares are expected to provide a partially franked 3.7% dividend in FY 2017 according to CommSec.

Investors could wait in hope for a pull back before investing, but if you plan on holding Transurban Group for the next decade or so, then I believe investing today at the current price will prove to be a rewarding investment.

Telstra Corporation Ltd (ASX: TLS)

In the current low interest environment I believe Telstra is a great option for retirees. At the current share price it is one of the more generous dividend payers on the S&P/ASX 200 with an estimated full year fully franked dividend of 5.3%. This is around 110 basis points higher than the market's average of 4.2%.

The good news is that this dividend appears to be more than sustainable thanks to the solid performance of its core businesses. In its half year results the company reported that it added an additional 121,000 retail fixed broadband customers and an impressive 235,000 net new retail mobile customers. This helped boost half-year profit to a massive $2.1 billion.

The growth of its core businesses may now be slowing, but there's still a lot of potential in other areas of the business. As well as its expansion into the Asia-Pacific region, I'm very optimistic about Telstra expanding its presence in the healthcare sector.

The company has been building out capabilities for providing solutions in numerous areas including primary, aged and residential care, hospitals, radiology, pharmacy, and health analytics. Rather promisingly it recently secured a $180 million three-year contract from the government to manage a new national cancer screening register from next year.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »